Searched for

ZYDUS DISCOVERY DMCC

US FDA pulls up Cadila for misbranding drug
The company has been researching on the drug to treat fatty liver disease or non-alcoholic steatohepatitis apart from diabetic dyslipidemia.
29 Dec, 2016, 12.15 AM IST
Cadila Healthcare misbranded Saroglitazar, says US FDA
In a December 21 letter to the company, the US FDA has said the “broad statements” made by the company as the “world’s first” is misleading...
28 Dec, 2016, 11.46 AM IST

Hot on Web